Compounds for enzyme inhibition

Details for Australian Patent Application No. 2005238445 (hide)

Owner Proteolix, Inc.

Inventors Musser, John H.; Laidig, Guy J.; Smyth, Mark S.; Chabala, John Clifford; Crews, Craig M.; Borchardt, Ronald T.; Bunin, Barry A.

Agent Shelston IP

Pub. Number AU-B-2005238445

PCT Pub. Number WO2005/105827

Priority 60/562,340 15.04.04 US; 60/620,573 20.10.04 US; 60/610,002 14.09.04 US; 60/610,001 14.09.04 US; 60/569,096 07.05.04 US; 60/610,159 14.09.04 US; 60/599,401 06.08.04 US

Filing date 14 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 3 May 2012

International Classifications

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

C07K 5/107 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/105827 Priority application(s): WO2005/105827

31 May 2007 Amendment Made

  The nature of the amendment is: Delete co-inventor Schneekloth, Jr John S

3 May 2012 Application Accepted

  Published as AU-B-2005238445

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238446-Neural proteins as biomarkers for nervous system injury and other neural disorders

2005238442-Process for preparing dipeptidyl IV inhibitors and intermediates therefor